Pharmaceutical News

RSS

Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases

Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University, a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory diseases.

4 May 2011

NCPA explains how PBM tools can reduce costs in Texas, other states

Texas and other states across the country could save billions in Medicaid without limiting access by transitioning to a more efficient and affordable pharmacy benefit model being used in Medicare and the commercial sector, the National Center for Policy Analysis announced in a new white paper, "Increasing the Cost-Effectiveness of Medicaid Drug Programs."

4 May 2011

FTC, FDA take action on unproven STD drug products

The U.S. Food and Drug Administration and the Federal Trade Commission today announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases.

4 May 2011

Ecstasy may cause long-term brain damage

Ecstasy - the illegal "rave" drug that produces feelings of euphoria and emotional warmth - has been in the news recently as a potential therapeutic. Clinical trials are testing Ecstasy in the treatment of post-traumatic stress disorder.

4 May 2011

AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada

During its quarterly meeting over the weekend, The Board of Directors of the AIDS Healthcare Foundation (AHF) adopted a resolution cautioning Gilead Sciences against seeking fast track FDA-approval for the expanded use of its best selling AIDS treatment, Truvada, as a possible form of pre-exposure prophylaxis (PrEP) to prevent the transmission of HIV.

4 May 2011

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

GenVec, Inc. today announced that it has entered into a second agreement with Merial, the animal health division of sanofi-aventis.

3 May 2011

Study: Dual medications do not hasten recovery from depression

Taking two medications for depression does not hasten recovery from the condition that affects 19 million Americans each year, researchers at UT Southwestern Medical Center have found in a national study.

3 May 2011

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates achieved 1,000-fold reduction in the levels of infectious virus in the lungs of animals with a lethal level of influenza virus infection.

3 May 2011

Lopinavir can combat HPV-related cervical cancer

A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus, say scientists.

3 May 2011

New study: Text-heavy labels can reduce acetaminophen overdose

While well known for relieving everyday aches and pains, few realize that when misused, acetaminophen can lead to acute liver failure and even death, often due to accidental overdose by an uninformed consumer. A new small study looked at what's missing in consumer education about acetaminophen and how to overcome those gaps.

3 May 2011

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

Has a bone density scan placed you at risk for osteoporosis, leading your doctor to prescribe a widely advertised bone-building medication? Not so fast! A University of Illinois study finds that an effective first course of action is increasing dietary calcium and vitamin D or taking calcium and vitamin D supplements.

3 May 2011

AHA recommends Omega-3 EPA/DHA intake for individuals with elevated triglyceride levels

The American Heart Association recently issued its first ever statement on triglyceride management that includes recommendations for Omega-3 EPA/DHA intake.

3 May 2011

CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review

Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.

3 May 2011

Desirudin more effective for VTE prevention in patients with renal impairment

Desirudin reduced major venous thromboembolism and post-operative bleeding compared with the standard of care, enoxaparin, in patients with poor kidney function undergoing orthopedic surgery, according to a poster presented at the Arteriosclerosis, Thrombosis and Vascular Biology meeting.

3 May 2011

Althea enters commercial drug supply agreement with Biotest

Althea Technologies, Inc. announced today that they have entered into a commercial supply agreement with Biotest Pharmaceuticals Corporation.

3 May 2011

Winner Medical's PurCotton products introduced at MICF 2011

Winner Medical Group Inc. a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported that its wholly-owned subsidiary, Shenzhen PurCotton Technology Ltd., participated in the 13th China International Mother-Infant-Child Products Fair held in the China International Exhibition Center, Beijing, on April 14-16, 2011.

3 May 2011

JPO issues patent to Silence Therapeutics' RNAi technology

Silence Therapeutics plc announces the issuance of patent 4,705,370, titled "Further Novel Forms of Interfering RNA Molecules," by the Japanese Patent Office.

3 May 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

3 May 2011

HIV drugs may also combat parasitic diseases: Study

Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria.

3 May 2011

Pharmaceutical News

Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases

NCPA explains how PBM tools can reduce costs in Texas, other states

FTC, FDA take action on unproven STD drug products

Ecstasy may cause long-term brain damage

AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

Study: Dual medications do not hasten recovery from depression

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

Lopinavir can combat HPV-related cervical cancer

New study: Text-heavy labels can reduce acetaminophen overdose

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

AHA recommends Omega-3 EPA/DHA intake for individuals with elevated triglyceride levels

CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review

Desirudin more effective for VTE prevention in patients with renal impairment

Althea enters commercial drug supply agreement with Biotest

Winner Medical's PurCotton products introduced at MICF 2011

JPO issues patent to Silence Therapeutics' RNAi technology

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

HIV drugs may also combat parasitic diseases: Study

More HIV infections linked to injection drug use in East Africa, report finds

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News